The return of the meme stock frenzy has led online retailer Blue Apron (APRN) to gain more than 90% over the past month. However, the rally is not fueled by…
Category archives: Stocks
As Rates Rise, 2 Mortgage REITs to Check out, and 1 to Ignore
Despite widespread uncertainties, REITs have achieved a strong performance in the last quarter, with FFO hitting a record high. Moreover, the Fed’s rate hike is boding well for mortgage REITs….
Freeport-McMoRan May Be Undervalued, but These 2 Stocks Offer More Bang for Your Buck
Amid the market uncertainty, investors must look for stocks that offer more bang for their buck! Freeport-McMoRan (FCX) is currently trading at a discount to its peers, but its fundamentals…
Minerva Neurosciences up More Than 100% This Week, but Is It a Better Pick Than Vertex Pharma?
Minerva Neurosciences (NERV) and Vertex Pharmaceuticals (VRTX) are expected to benefit from the rising number of chronic diseases and continued technological advancements in the industry. Since NERV has gained more…
3 Buy-Rated ETFs to Fill out Your Portfolio This Summer
Since inflation is still hovering around 40-year highs, the Fed will likely maintain its hawkish stance, which could keep the market under pressure. Therefore, it could be wise to invest…
Comcast Stock Is Only TV Entertainment “Buy,” These 2 Others Are Duds
Amid soaring prices, entertainment giants have failed to retain their optimal pandemic-era performances. However, demand for TV entertainment remains robust. Quality TV entertainment stock Comcast (CMCSA) could be worth buying…
Roblox up Nearly 65% Since Mid-June, Time to Go All In?
Gaming platform operator Roblox (RBLX) reported disappointing second-quarter 2022 results. Furthermore, its near-term prospects look bleak owing to slowing demand, as evident from the significant decline in bookings. However, RBLX…
1 Food Stock That Is Well Worth Watching
Food giant Kellogg (K) has delivered stable returns this year, despite the macroeconomic headwinds. Moreover, given its massive reach and brand popularity, the company is expected to witness steady growth….
Is Cisco Systems a Buy After Mixed Earnings Results?
Networking giant Cisco (CSCO) reported mixed fourth-quarter earnings results but provided impressive guidance for fiscal 2023, supported by strong demand for cloud computing infrastructure and telecom networks combined with easing…
Better Buy: Axsome Therapeutics vs. Johnson & Johnson
Axsome Therapeutics (AXSM) and Johnson & Johnson (JNJ) are expected to benefit from the rising number of chronic diseases and continued technological advancements in the pharmaceutical sector. But which of…